LONDON/COPENHAGEN (Reuters) -Obesity drugmaker Novo Nordisk's CFO said on Wednesday he was sceptical that U.S. President ...

injection 1 mg and other semaglutide-containing medicines through authorized distributors of Novo Nordisk. The North Carolina Attorney General also issued a warning about fake weight loss drugs ...

Welcome to the Q1 2025 Novo Nordisk A/S Earnings Conference Call ... Indiana and Casa, North Carolina. The existing U.S. tariffs does not materially change our financial outlook for 2025.

Pharmaceutical company Novo Nordisk (NVO) came out swinging Wednesday ... It's biologic manufacturing taking place in North Carolina and supplied to Americans. So we are proud about that, and ...

Coming up, we've got our conversation with the CEO Novo Nordisk as the company trims ... It's biological.manufacturing taking place in North Carolina and uh supplied to to to Americans so we ...

Pharma CEOs have told EC President von der Leyen they may shift operations towards the US as trade tensions escalate.

Novo Nordisk announced last year that it is investing $4.1 billion to build a new facility in Clayton, North Carolina.

Novo Nordisk is one of the many that has started onshoring plans to bring more manufacturing to the US, with its $4.1bn expansion in Clayton, North Carolina. According to the EFPIA, the US now ...

A Novo Nordisk spokesperson echoed the positivity ... logistics and operations support in Clayton, North Carolina, alone, according to the spokesperson. Roles such as these may attract not only ...